Publication: The clinical efficacy and safety of Rituximab in pediatric kidney transplant recipients with refractory epstein-barr virus: a case-control study
dc.contributor.coauthor | Arpali, Emre | |
dc.contributor.department | TIREX (Koç University Transplant Immunology Research Centre of Excellence) | |
dc.contributor.department | KUH (Koç University Hospital) | |
dc.contributor.department | School of Medicine | |
dc.contributor.kuauthor | Demir, Erol | |
dc.contributor.kuauthor | Pehlivanoğlu, Cemile | |
dc.contributor.kuauthor | Akyollu, Başak | |
dc.contributor.kuauthor | Ünlügedik, Özlem | |
dc.contributor.kuauthor | Karataş, Cihan | |
dc.contributor.kuauthor | Demirbaş, Kaan Can | |
dc.contributor.kuauthor | Töle, Neşe | |
dc.contributor.kuauthor | Erbey, Mehmet Fatih | |
dc.contributor.kuauthor | Bilge, İlmay | |
dc.contributor.kuauthor | Koçak, Burak | |
dc.contributor.schoolcollegeinstitute | KUH (KOÇ UNIVERSITY HOSPITAL) | |
dc.contributor.schoolcollegeinstitute | Research Center | |
dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
dc.date.accessioned | 2025-03-06T21:00:42Z | |
dc.date.issued | 2024 | |
dc.description.indexedby | WOS | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.identifier.doi | 10.1097/01.tp.0001065976.60697.e0 | |
dc.identifier.eissn | 1534-6080 | |
dc.identifier.issn | 0041-1337 | |
dc.identifier.issue | 9S | |
dc.identifier.quartile | Q1 | |
dc.identifier.uri | https://doi.org/10.1097/01.tp.0001065976.60697.e0 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/27947 | |
dc.identifier.volume | 108 | |
dc.identifier.wos | 1375600800022 | |
dc.keywords | Rituximab | |
dc.keywords | Pediatric kidney transplant | |
dc.keywords | Epstein-Barr virus | |
dc.keywords | Refractory infection | |
dc.keywords | Immunosuppression | |
dc.keywords | Case-control study | |
dc.language.iso | eng | |
dc.publisher | Lippincott Williams and Wilkins | |
dc.relation.ispartof | Transplantation | |
dc.subject | Immunology | |
dc.subject | Surgery | |
dc.subject | Transplantation | |
dc.title | The clinical efficacy and safety of Rituximab in pediatric kidney transplant recipients with refractory epstein-barr virus: a case-control study | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Pehlivanoğlu, Cemile | |
local.contributor.kuauthor | Demir, Erol | |
local.contributor.kuauthor | Akyollu, Başak | |
local.contributor.kuauthor | Ünlügedik, Özlem | |
local.contributor.kuauthor | Karataş, Cihan | |
local.contributor.kuauthor | Demirbaş, Kaan Can | |
local.contributor.kuauthor | Töle, Neşe | |
local.contributor.kuauthor | Erbey, Mehmet Fatih | |
local.contributor.kuauthor | Bilge, İlmay | |
local.contributor.kuauthor | Koçak, Burak | |
local.publication.orgunit1 | SCHOOL OF MEDICINE | |
local.publication.orgunit1 | Research Center | |
local.publication.orgunit1 | KUH (KOÇ UNIVERSITY HOSPITAL) | |
local.publication.orgunit2 | TIREX (Koç University Transplant Immunology Research Centre of Excellence) | |
local.publication.orgunit2 | KUH (Koç University Hospital) | |
local.publication.orgunit2 | School of Medicine | |
relation.isOrgUnitOfPublication | 29cd9ca5-6407-4582-92b6-788bc6f33efd | |
relation.isOrgUnitOfPublication | f91d21f0-6b13-46ce-939a-db68e4c8d2ab | |
relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isOrgUnitOfPublication.latestForDiscovery | 29cd9ca5-6407-4582-92b6-788bc6f33efd | |
relation.isParentOrgUnitOfPublication | 055775c9-9efe-43ec-814f-f6d771fa6dee | |
relation.isParentOrgUnitOfPublication | d437580f-9309-4ecb-864a-4af58309d287 | |
relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | 055775c9-9efe-43ec-814f-f6d771fa6dee |